A Study of Semagacestat for Alzheimer's Patients

Clinical trial NCT01035138 · COMPLETED

Trial details

NCT number: NCT01035138
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2009-12-01
Primary completion: 2011-04-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.